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Cytotoxic T-lymphocyte (CTL) responses to infectious bronchitis virus (IBV) were determined at regular
intervals between 3 and 30 days postinfection (p.i.). The maximum response with 82% lysis of labeled target
cells was detected at 10 days p.i. The specific CTL response did not begin to decline until the amount of virus,
which peaked at day 8 p.i. in both the kidneys and lungs, started to decrease. Clinical respiratory signs of
illness also correlated with amount of virus. CTL activity was shown to be major histocompatibility complex
(MHC) class restricted because the lysis of MHC-mismatched targets was negligible, and lysis was mediated
by CD81 CD42 T cells, as the CTL response could be abolished with removal of CD81 CD42 but not CD41
CD82 lymphocytes. In contrast, immunoglobulin M (IgM) antibody was not detected until day 10 p.i., and
levels peaked at day 12 p.i.; IgG antibody levels were minimal until day 15 p.i. but continued to increase
exponentially until day 30 p.i., the last day examined. In summary, CTL responses correlated with initial
decreases in infection and illness.
Cytotoxic T lymphocytes (CTL) provide a critical arm of the
immune system in eliminating autologous cells expressing for-
eign antigen. Unlike humoral immunity, the specificity of CTL
activation depends on membrane receptors rather than se-
creted molecules, and antigen receptors of CTL interact with
peptide determinants only in association with matched major
histocompatibility complex (MHC) molecules (11, 29). Virus-
specific CTL have been shown to be important, if not critical,
for resolution of infection and elimination of viral shedding
(17, 21, 23).
Most virus-specific CTL activity identified is MHC class I
restricted and mediated by CD81 CD42 T lymphocytes (1, 22)
and is targeted toward cells that endogenously express viral
determinants. Although most of our current understanding of
cellular immunity comes from human and mouse studies, mo-
lecular counterparts to mammals tend to be conserved in the
bird (6, 10, 24). Limited CTL studies have indicated that avian
CTL functions parallel those for mammals (18, 32). For exam-
ple, MHC-restricted, CD81 T-cell-mediated lysis of avian leu-
kosis retrovirus-infected target cells has been found in chicks
(28).
Infectious bronchitis virus (IBV), a prototype of the Coro-
naviridae family, causes a highly contagious respiratory disease
of chickens that is particularly severe for very young chicks, in
which signs of illness include tracheal rales, coughing, sneez-
ing, and nasal discharge. Some strains also have tropism for the
urinary tract, causing kidney damage (5, 7, 9, 15) and serious
production losses in laying hens (8). Outbreaks of disease
associated with IBV infection can occur in vaccinated flocks.
These vaccine failures probably result from antigenic variants
of IBV emerging from wild-type or vaccine viruses by point
mutations or genome RNA-RNA recombination (31).
Whereas current vaccines have targeted induction of viral neu-
tralizing antibody, development of effective prophylactic con-
trol of IBV should include antigen preparations that induce
CTL as well as humoral immunity. IBV-specific CTL have not
been demonstrated, although murine CD4 T-cell epitopes
were identified on the nucleocapsid protein of IBV (3). How-
ever, mice are not natural hosts for IBV. CTL from murine
hepatitis virus-infected mice that lysed target cells expressing
whole virus and the nucleocapsid alone have been identified
(26, 33). In the present study, IBV-specific CTL responses
were examined in chicks. MHC class I-restricted and CD81
T-cell-mediated lysis of target cells infected with IBV were
identified, and maximal activity was found to occur on day 10
postinfection (p.i.). The virus control of replication correlated
with CTL activity.
MATERIALS AND METHODS
Source of virus. The nephropathogenic Gray strain of IBV was propagated by
inoculating the allantoic sacs of 11-day-old chicken embryos, and allantoic fluid
harvested 36 h p.i. was collected as the source for viral inoculation (25). Tissue
culture-adapted virus was propagated in primary chicken kidney (CK) cells and
in an established CK cell line before harvesting at 48 h p.i.
Experimental animals. Embryonated eggs of inbred (B12/B12) and outbred
(R68C) chickens were obtained from Hy-VAC (Adel, Iowa), and SPAFAS In-
corporated (Preston, Conn.), respectively. Eggs were hatched in our laboratory,
and chicks were housed in a specific-pathogen-free environment at the Labora-
tory Animal and Resources Facility, Texas A&M University, College Station.
Chicks were inoculated at 4 weeks by the nasal-oral routine with 106 egg infec-
tious doses (EID50) of the Gray strain. At 5-day intervals, chicks were recorded
as experiencing clinical illness when they displayed signs of coughing, sneezing,
or dyspnea.
Cell culture. A CK cell line was established from 10-day-old chicks (B12/B12).
Briefly, CK cells were dispersed with trypsin digestion and cultured in a 75-cm2
tissue culture flask which was coated overnight with 1 mg of calf collagen (Sigma
Chemical Co., St. Louis, Mo.) per ml in water at room temperature. After air
drying, tissue culture flasks were sterilized with UV light for 6 h (20). The CK
adherent cells were continuously cultured by passing approximately every 4 days
in MEM (minimal essential medium) supplemented with 10% chicken serum
(Sigma), 1.4% sodium pyruvate, and 1.4% MEM nonessential amino acids. After
50 passages, the established CK cell line was used for target cells.
Effector cell preparation. Splenocytes from infected or uninfected chicks were
used as the source of effector cells. Spleens from chicks were collected at various
days p.i. before the single-cell suspension was minced and passaged through a
150-mesh stainless-steel sieve to remove the connective tissue fragments. Spleens
from six chicks were pooled to obtain a sufficient quantity of T lymphocytes.
Lymphocytes were isolated by centrifuging 5 ml of the diluted spleen cells for 20
min at 1,500 rpm through 5 ml of Ficoll-Hypaque gradient (Histopaque; Sigma).
Viable cells were collected from the interface, washed three times with phos-
phate-buffered saline (PBS; pH 7.2), and washed once with RPMI 1640. Mac-
rophages were removed by incubating 5 3 107 cells in 75-cm2 tissue culture flasks
with RPMI 1640 supplemented with 10% chicken serum (Sigma), 2 mM L-
glutamine, 5 3 1025 M 2-mercaptoethanol, 0.01 mM sodium pyruvate, and 0.1











moved by passing the cell suspension through a nylon wool fiber column previ-
ously equilibrated with complete medium (16).
Depletion of CD41 and CD81 T cells. The CD41 and CD81 antigen-bearing
lymphocytes were separated by a modification of the panning method of Mage et
al. (19). Briefly, 75-cm2 tissue culture flasks were incubated overnight at room
temperature with goat anti-mouse immunoglobulin G (IgG; 60 mg/ml in PBS
[pH 7.2]). T cells purified as described above were labeled with a 1:500 dilution
of either mouse anti-chicken CD4 or anti-chicken CD8 monoclonal antibody
(Southern Biotechnology Associates, Birmingham, Ala.) in PBS. After the cells
were washed three times with ice-cold PBS (pH 7.2) and the concentration was
adjusted to 107 cells per ml in PBS, the antibody-labeled cells were added to goat
anti-mouse IgG-coated plates and incubated at room temperature for 30 min.
The suspensions were swirled gently before incubation for an additional 30 min
at room temperature. Nonadherent cells were decanted from the plates following
gentle agitation.
Flow cytometry. T lymphocytes were incubated on ice for 30 min with 1:50
dilution in PBS of mouse monoclonal antibodies specific for chicken CD4 or
CD8 antigen before being washed three times with PBS (pH 7.2) and incubated
on ice with 1:50 dilution of fluorescein isothiocyanate-labeled goat anti-mouse
IgG (1:50) in PBS for 30 min. After five washes with PBS, the reaction samples
were fixed with 2% formaldehyde in PBS and counted with a FACSCALIBUR
(Becton Dickinson, San Jose, Calif.).
Cytotoxic T-cell assay. Splenic lymphocytes were tested for cytotoxic activity
against syngeneic and heterologous target cells by using a modification of the
procedures described by McGuire et al. (20). Target cells (2 3 104 per well) were
incubated for 24 h at 41°C with 6% CO2 in a 96-well plate. Target cells were
inoculated with 106 EID50 of CK cell-adapted Gray strain per well for 5 h before
labeling with 51Cr. Cells were labeled for 90 min with 5 mCi of 51Cr per well in
100 ml of MEM supplemented with 1% sodium pyruvate, 1% MEM nonessential
amino acid, and 5% syngeneic chicken serum. Various ratios of effector and
target cells (E/T ratios) were incubated for 24 h in 200 ml of complete RPMI 1640
at 41°C. After removal of 100 ml of supernatant, the amount of 51Cr release was
determined. Percent specific lysis equaled (E 2 S/M 2 S) 3 100, where E is the
mean of three test wells, S is the mean of spontaneous release from the three
target cells without effector cells, and M is the mean maximal release from the
three target cells with 3% Triton X-100.
ELISA. Gray strain viral antigen was coated onto 96-well plates by adding 100
ml of whole virus diluted in carbonate-bicarbonate coating buffer (pH 9.6) at the
concentration of 50 ng per well, and the plates were incubated overnight at 4°C
before being washed three times with PBS–0.05% Tween 20 (4). Each well was
blocked with 100 ml of 1% bovine serum albumin for 2 h at room temperature.
After three washes with PBS–0.05% Tween 20, 100 ml of serum diluted in PBS
(pH 7.2) was added to each well. The plates were incubated for 1 h at room
temperature and washed three times with PBS–0.05% Tween, 100 ml of horse-
radish peroxidase-conjugated rabbit anti-chicken IgG diluted in PBS (1:2,000)
was added, and the plates were incubated for 1 h at room temperature and again
washed three times with PBS–0.05% Tween. After 100 ml of 2,29-azinobis(3-
ethylbenzthiazoline sulfonic acid) (ABTS) peroxidase substrate (Kirkegaard &
Perry Laboratories, Gaithersburg, Md.) was added to each well, the plates were
incubated for 20 min in the dark, and the optical density was determined at 405
nm on an enzyme-linked immunosorbent assay (ELISA) spectrophotometer.
Indirect immunofluorescence assay. CK cells were cultured overnight in six-
well plates at 41°C before being infected with Gray strain IBV for 48 h. Cells
were collected by trypsinization and fixed with 1.8% formaldehyde for 20 min on
ice. The fixed CK cells were resuspended to 105 cells per ml in PBS and spotted
on the wells of microscope slides (Celline Associates, Inc., Newfield, N.J.) before
air drying. The dried CK cells were dipped in PBS for 30 min, incubated on ice
with Gray anti-mouse polyclonal antibody for 30 min, and then washed three
times with cold PBS–0.05% Tween 20. CK cells were incubated on ice with
fluorescein isothiocyanate-labeled goat anti-mouse IgG for 30 min, washed five
times with cold PBS–0.05% Tween 20, and then evaluated under a UV micro-
scope (4).
EID50. Lungs and kidneys were collected from 28-day-old syngeneic chickens
at various days after infection with Gray strain IBV. Each organ was weighed and
homogenized, and then a 10% (wt/vol) of dispersed cell suspension was prepared
in Eagle’s MEM containing penicillin (200 U/ml) and streptomycin (200 mg/ml).
After standing for 90 min at 4°C, cells were pelleted by centrifugation for 20 min
at 2,000 3 g, and serial 10-fold dilutions were prepared in Eagle’s MEM. One-
tenth milliliter of each virus dilution was injected into each of six 11-day-old
embryonated chicken eggs (8a). The eggs were sealed with collodion and incu-
bated at 40°C for 5 days, and then the embryos were examined for dwarfing. The
EID50 was calculated by method of Reed and Muench as described by Burleson
et al. (4): (log dilution above 50%) 1 (proportional distance 3 log dilution
factor) 5 log EID50.
RESULTS
Detection of IBV-specific CTL. CK cells established from
10-day-old syngeneic chickens (B12/B12) were used as CTL
targets. The expression of IBV Gray strain antigens in infected
cells was evaluated by indirect immunofluorescence following
infection of 5 3 106 cells with 106 EID50 of IBV (Fig. 1).
Positive fluorescence in about 90% of infected cells was de-
tected only in the cytoplasm (Fig. 1A), whereas no fluores-
cence was detected in the uninfected control CK cells (Fig.
1B).
To optimize conditions for detection of CTL, unstimulated
splenic T cells were collected from IBV-infected and unin-
fected syngeneic chicks at 5 day p.i. and their IBV-specific
cytolytic activity evaluated at various incubation times at an
E/T ratio of 100:1. The 15- and 24-h incubations resulted in
22.5 and 36% lysis, respectively, of infected target cells (Fig. 2).
Incubation periods extending past 24 h resulted in an unac-
ceptable spontaneous release of more than 30%. Since the
IBV-specific CTL lysis was maximal at 24 h of incubation, with
effector and target cells exhibiting less than 30% spontaneous
release, this incubation time was used in the subsequent assays.
The unstimulated T cells from spleens of IBV-uninfected
chicks caused negligible lysis of less than 1%.
CTL activity in IBV-infected chicks was greatest at 10 days
p.i. The cytolytic activity of splenic T cells from syngeneic
infected chicks was evaluated between 3 and 30 days p.i. at an
E/T ratio of 100:1 (Fig. 3A). IBV-specific CTL activity was
detected at day 3 p.i., with 22.9% release of radioactivity. The
maximum specific lysis was observed at day 10 p.i., with 82.8%
lysis. The CTL response decreased on days 15 and 20, with
release of radioactivity of 46.30 and 38%, respectively. The
FIG. 1. Detection of IBV antigens in IBV-infected (A) and uninfected (B)
CK cells, using indirect immunofluorescence assay.
FIG. 2. Incubation time for optimal CTL lysis. Splenic T cells were collected
from six chicks at day 5 p.i., pooled, and incubated for various times with infected
syngeneic CK target cells at an E/T ratio of 100:1. Percent lysis of syngeneic
target cells by splenic CTL of IBV-infected chicks is represented by open bars;
percent lysis of syngeneic target cells by splenic CTL of uninfected chicks is
represented by dark bars.










CTL activity continued to decrease to 19.23% on day 30 p.i.
The CTL activity of spleen cells from uninfected chicks was
negligible.
Amount of virus isolated from lungs and kidneys was great-
est at 8 days p.i. To determine the viral titer in two target
organs of IBV, lungs and kidneys were collected from Gray
strain IBV-infected chicks at various days p.i., and the viral
titer (EID50) was determined. Virus was detected as early as
day 3 p.i. in lungs (104.3 EID50) and kidneys (10
2.5 EID50). The
viral titer increased continuously until day 8 p.i., with a maxi-
mum of 109.5 EID50 in lungs and 10
8.5 EID50 in kidneys. How-
ever, the viral titers started to decrease from day 9 until day
30 p.i. in both lungs and kidneys (Fig. 3A). Clinical signs of
disease in chicks infected with Gray strain IBV were also ob-
served (Table 1). Respiratory symptoms appeared between 5
and 10 days p.i., and most chicks recovered before day 15 p.i.
The correlation of viral replication and clinical signs suggests
that IBV-specific CTL played an important role in resolving
the illness.
IgG antibody titer increased exponentially in contrast to
CTL activity. The chicken sera were collected at various days
p.i., and the antibody titer was evaluated by ELISA. The IgG
antibody titer increased exponentially from day 10 p.i., when
CTL activity was maximum, whereas the highest titer of IgG
antibody was observed at day 30 p.i., the last day examined,
when CTL activity dropped to the lowest level. IgM antibodies
were detectable at day 10 p.i. and peaked at day 12 p.i. (Fig.
3B).
CTL activity was MHC class I restricted, mediated by
CD81. A dose-responsive increase in specific lysis of syngeneic
target cells infected with 106 EID50 of Gray strain IBV by
unstimulated splenic T cells from chickens at day 10 p.i., was
observed, with maximum lysis of 82% at an E/T ratio of 100:1.
Specific lysis of the IBV-infected heterologous target cell line
was observed, with maximum lysis of only 11.67% at an E/T
ratio of 100:1. Therefore, the IBV-specific lysis of target cells
by chicken CTL was mostly MHC restricted. The unstimulated
splenic T cells from uninfected chicks did not indicate any
detectable lysis of the syngeneic CK cells infected with Gray
strain IBV (Fig. 4).
The CD81 T cells or CD41 T cells were removed by the
panning method from the unstimulated splenic T cells of
chicks at day 10 p.i. to determine which subpopulations of T
cells mediate lysis of IBV-infected CK target cells. Lysis of
target cells by T-cell populations depleted of CD81 T cells was
minimal, with maximum lysis of only 6.7% at an E/T ratio of
40:1. Meanwhile, the unstimulated splenic T cells depleted of
CD41 T cells mediated the specific lysis in a dose-responsive
manner, with the maximum cytolysis of 38.3% at an E/T ratio
of 40:1. Control T cells from uninfected chicks did not mediate
any detectable lysis of IBV-infected target cells (Fig. 5).
The phenotypes of depleted cell populations (106 T cells per
ml) were evaluated by flow cytometry (Fig. 6). All cells exam-
ined were CD31 whether they were treated with anti-CD4 or
FIG. 3. (A) Time course of the specific CTL response and viral replication in
chicks infected with IBV. Effector T cells were collected from spleens of six
chicks infected with 106 EID50 of Gray strain IBV, pooled, and incubated for 24 h
with 51Cr-labeled syngeneic target cells at an E/T ratio of 100:1. Squares, lysis of
target cells by effector T cells from spleens of IBV infected chicks; diamonds,
lysis of target cells by control effector T cells from spleens of IBV uninfected
chicks; circles, EID50 in lungs; triangles, EID50 in kidneys. (B) Time course of
antibody response in IBV-infected chicks. At various days p.i., anti-IBV sera
were collected from six chicks infected with Gray strain IBV and pooled before
quantitation by ELISA, using Gray strain whole viral antigen. Squares, IgM;
circles, IgG. O.D., optical density.
FIG. 4. Demonstration of MHC class I restriction of IBV-specific CTL. At 10
days p.i., effector splenic T cells were collected from six IBV-infected chicks and
pooled. Splenic effector cells were incubated for 24 h at an E/T ratio of 100:1 with
CK target cells. Squares, IBV-infected syngeneic CK target cells; diamonds,
heterologous IBV infected target cells; circles, uninfected syngeneic target cells.
TABLE 1. Number of IBV-infected chicks showing clinical signs
of illness
Clinical signa











Respiratory illness 7 15 1 1 1
Death 0 0 2 0 0
a Twenty chicks in either infected or uninfected groups were examined. Only
illness from the infected chicks is described, as none of the uninfected control
chicks showed clinical signs of illness. Fifteen of 20 infected showed respiratory
illness.










anti-CD8. After depletion with CD4 antibody, all remaining
cells were characterized as CD31 CD42 CD81 (Fig. 6A to C),
and depletion with CD8 antibody removed all detectable cells
with CD8, leaving only CD31 CD41 CD82 T cells (Fig. 6D to
F). Therefore, removal of CD31 CD42 CD81 T cells corre-
lated with depletion of the IBV-specific CTL response,
whereas the CTL response was not affected by removal of cells
with the CD31 CD41 CD82 phenotype.
DISCUSSION
The role of CTL in inhibiting coronavirus replication has not
been previously examined. The CTL response of chickens to
avian leukosis virus and the response of mice to murine hep-
atitis virus have been described but not correlated with acute
viral infection. In this report, we have shown that during acute
infection, IBV induces vigorous specific CTL activity. This
cellular response can be correlated more closely to the initial
decline in viral load than the subsequent specific humoral
responses.
As in mammals, chicken CTL lysis of virus-infected target
cells is mostly MHC restricted. CTL lysis of syngeneic CK
target cells was dose responsive; the CTL lysis of heterologous
CK cells was also dose responsive, but the maximum was less
than 14% of the cytolytic response. The lysis of heterologous
target cells by splenic T cells may be due to natural killer cells,
which do not require MHC restriction to kill virus-infected
target cells (14, 30). In addition, the depletion of T-lymphocyte
subtypes and phenotypic determination of the remaining cells
indicated that specific lysis by splenic T cells from IBV-infected
chickens was mediated by CD81 CD42 T cells, not by CD41
CD82 T cells.
The kinetics of the IBV-specific CTL response is similar to
the CTL response described for avian leukosis virus in chickens
(28). In addition, a maximum murine CTL response to Sendai
virus was observed at about 12 p.i. (27). In contrast, maximum
direct CTL responses in horses against equine herpesvirus
were detected by 2 and 3 weeks p.i. (1). The impact of animal
species and viral pathogenesis on the nature of the CTL re-
sponse can be elucidated only with the characterization of CTL
responses following infection of greater varieties of animals
with additional viruses.
Viral infection in both lungs and kidneys shown as log titra-
tions in embryonated chicken eggs was biphasic, with maxi-
mum levels observed at day 8 p.i., and the clinical signs of
respiratory distress correlated with viral infection. The decline
of viral amount at 15 days p.i. was followed by a decline in the
specific CTL activity. However, the transient presence of spe-
cific IgM antibody, although somewhat delayed in comparison,
could also be roughly correlated with viral infection. In con-
trast, the IgG antibody levels were relatively low until after day
15 p.i., when viral amounts in IBV target organs were 102.5
FIG. 5. CD81 T-cell-mediated lysis of IBV infected target cells. Splenic T
lymphocytes from chicks infected with IBV were collected at day 10 p.i. and
depleted of CD81 T cells or CD41 T cells before evaluation of the CTL re-
sponses. Symbols represent lysis of infected targets with splenic effector T cells
depleted of CD41 cells (squares), with those depleted of CD81 cells (diamonds),
and with undepleted cells (closed circles). Lysis of uninfected CK target cells with
effector cells depleted of CD41 T cells is shown by open circles.
FIG. 6. Identification by flow cytometry of the T-lymphocyte phenotype of splenic cells depleted of CD4 or CD8. Control splenic T cells were stained with only the
secondary antibody. Splenic T lymphocytes depleted of CD41 T cells were stained with mouse anti-chicken CD4 monoclonal antibody (A), with CD8 monoclonal
antibody (B), and with CD3 monoclonal antibody (C). Splenic T lymphocytes depleted of CD81 T cells were stained with CD4 monoclonal antibody (D), with CD8
monoclonal antibody (E), and with CD3 monoclonal antibody (F).










EID50, compared to 10
8 EID50 on day 8. Chicks infected with
IBV began showing respiratory clinical signs between days 5
and 10 p.i., and most recovered from illness before day 15. The
resolution of clinical illness also suggests that IBV-specific
CTL played a major role in pathogenesis of acute viral infec-
tion.
The CTL response declined with the appearance of humoral
immune response, especially IgG, which is described as critical
in viral neutralization. The mechanism which the chicken im-
mune system uses to switch from cellular immunity to humoral
immunity after IBV infection remains to be elucidated. Al-
though helper T-cell subtypes have not been characterized in
chicks, it seems likely that until day 15 p.i., the Th1 subtype of
CD41 T cells producing lymphokines, such as interleukin-2
(IL-2), gamma interferon, and tumor necrosis factor beta, in-
volved in cellular immunity may be the predominant helper T
cells, but after day 15 p.i., the Th2 subtype of CD41 T cells,
involved in induction of humoral immunity and producing
IL-4, IL-5, IL-10, and IL-13, may replace Th1 cells.
At the later stage of IBV infection, the chicken immune
system may depend on humoral immunity to control viral in-
fection. However, these results overall indicate that the
chicken immune system may utilize specific CTL to eliminate
IBV at the early stage of acute infection. The early CTL re-
sponses to individual structural polypeptides are now being
determined. Although IBV-specific CTL activity correlated
with clearance of virus from target organs, the absolute role of
CTL can be determined only in the absence of antibody. Hu-
moral immunity can be virtually eliminated following bursec-
tomy of late-stage chicken embryos (12, 13). Chickens, in gen-
eral, will prove to be a unique animal model for determining
the role of immunity in controlling viral pathogenesis. Unlike
the case for mammals, immune cells can be easily manipulated
in the embryo; moreover, inbred strains are readily available,
and the pathogenesis of and immune responses to viral infec-
tions are similar to those in mammals. Adoptive transfer stud-
ies and identification of T-cell epitopes on IBV structural pro-
teins are in progress.
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